Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: ADAPTIVE BIOTECHNOLOGIES CORPORATION
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2022-11-10 to 2023-05-09
Current total value of award: $308400
Description: COVID 19 FUNDED IMMUNOSEQ SEQUENCING SERVICES FOR COVID-19 RESEARCH PROJECT